Ledger.Open graph →

SEC Form D · filed October 28, 2019

ReAlta Life Sciences, Inc

Offering

$12.0M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

NORFOLK, VA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Ulrich Thienel · NORFOLK, VAExec · Director Thomas K. Mccarter · NORFOLK, VAExec John K. Rickman · NORFOLK, VAExec Frank Gadams · NORFOLK, VADirector Barry Strasnick · NORFOLK, VADirector Edward Heidt, Jr · NORFOLK, VADirector Neel Krishna · NORFOLK, VAExec Kenji Cunnion · NORFOLK, VAExec · Director Scott Neal · GREELEY, CODirector Oren N. Shill · Oceanside, CAExec · Director Mark Khuri · BEND, ORDirector Sean Hopkins · GREELEY, COExec Jason Reichl · GREELEY, CODirector John Polchin · Lehi, UTExec Steve N. Dietlin · Oceanside, CAExec · Director Owen Davis · Brooklyn, NYExec John Harding · NORFOLK, VAExec · Director Greg E. Jensen · Belgrade, MTExec · Director Angela M. Duskey · Youngstown, OHExec · Director John M. O'Donnell · PITTSBURGH, PAExec Douglas A. Nelson, Jr · PITTSBURGH, PADirector Joseph T. Samosky · PITTSBURGH, PADirector Clayton Wood · SEATTLE, WADirector James Wang · SEATTLE, WAExec Yongbai Choi · SEATTLE, WAExec John Harding · NORFOLK, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗